Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Eriksson, Urs (7102875592)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
    (2021)
    Garcia-Pavia, Pablo (57197883068)
    ;
    Rapezzi, Claudio (7005883289)
    ;
    Adler, Yehuda (7005992564)
    ;
    Arad, Michael (7004305446)
    ;
    Basso, Cristina (7004539938)
    ;
    Brucato, Antonio (7006007796)
    ;
    Burazor, Ivana (24767517700)
    ;
    Caforio, Alida L.P. (7005166754)
    ;
    Damy, Thibaud (6506337417)
    ;
    Eriksson, Urs (7102875592)
    ;
    Fontana, Marianna (16306839900)
    ;
    Gillmore, Julian D. (7003539031)
    ;
    Gonzalez-Lopez, Esther (56453004900)
    ;
    Grogan, Martha (7004085182)
    ;
    Heymans, Stephane (6603326423)
    ;
    Imazio, Massimo (55787131200)
    ;
    Kindermann, Ingrid (6603127742)
    ;
    Kristen, Arnt V. (7801324099)
    ;
    Maurer, Mathew S. (35515053700)
    ;
    Merlini, Giampaolo (7006059649)
    ;
    Pantazis, Antonis (6508359030)
    ;
    Pankuweit, Sabine (7003360984)
    ;
    Rigopoulos, Angelos G. (6701402043)
    ;
    Linhart, Ales (7004149017)
    Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions. Thanks to advances in imaging techniques and the possibility of achieving a non-invasive diagnosis, we now know that cardiac amyloidosis is a more frequent disease than traditionally considered. In this position paper the Working Group on Myocardial and Pericardial Disease proposes an invasive and non-invasive definition of cardiac amyloidosis, addresses clinical scenarios and situations to suspect the condition and proposes a diagnostic algorithm to aid diagnosis. Furthermore, we also review how to monitor and treat cardiac amyloidosis, in an attempt to bridge the gap between the latest advances in the field and clinical practice. © European Society of Cardiology 2021
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases
    (2021)
    Garcia-Pavia, Pablo (57197883068)
    ;
    Rapezzi, Claudio (7005883289)
    ;
    Adler, Yehuda (7005992564)
    ;
    Arad, Michael (7004305446)
    ;
    Basso, Cristina (7004539938)
    ;
    Brucato, Antonio (7006007796)
    ;
    Burazor, Ivana (24767517700)
    ;
    Caforio, Alida L. P (7005166754)
    ;
    Damy, Thibaud (6506337417)
    ;
    Eriksson, Urs (7102875592)
    ;
    Fontana, Marianna (16306839900)
    ;
    Gillmore, Julian D (7003539031)
    ;
    Gonzalez-Lopez, Esther (56453004900)
    ;
    Grogan, Martha (7004085182)
    ;
    Heymans, Stephane (6603326423)
    ;
    Imazio, Massimo (55787131200)
    ;
    Kindermann, Ingrid (6603127742)
    ;
    Kristen, Arnt V (7801324099)
    ;
    Maurer, Mathew S (35515053700)
    ;
    Merlini, Giampaolo (7006059649)
    ;
    Pantazis, Antonis (6508359030)
    ;
    Pankuweit, Sabine (7003360984)
    ;
    Rigopoulos, Angelos G (6701402043)
    ;
    Linhart, Ales (7004149017)
    Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions. Thanks to advances in imaging techniques and the possibility of achieving a non-invasive diagnosis, we now know that cardiac amyloidosis is a more frequent disease than traditionally considered. In this position paper the Working Group on Myocardial and Pericardial Disease proposes an invasive and non-invasive definition of cardiac amyloidosis, addresses clinical scenarios and situations to suspect the condition and proposes a diagnostic algorithm to aid diagnosis. Furthermore, we also review how to monitor and treat cardiac amyloidosis, in an attempt to bridge the gap between the latest advances in the field and clinical practice. © The Author(s), 2021.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback